Taevas
New ZealandMedical Devices
Legal Representation
Legal Representation for Medical Devices in New Zealand
Taevas Global provides qualified in-country legal representation so medical devices manufacturers can meet Medsafe's regulatory requirements and enter the New Zealand market with confidence. From sponsor obligations to post-market compliance, we act as yo
Market
New Zealand
Industry
Medical Devices
Service
Legal Representation
Regulator
Medsafe (Ministry of Health)
Timeline
4-6 weeks to appoint
What We Deliver
Six Pillars of New Zealand Medical Devices Intelligence
Our six interconnected service pillars give medical devices manufacturers a complete, compliant, and commercially ready foundation for the New Zealand market.
01
Medsafe Sponsor Representation
New Zealand law requires every overseas medical device manufacturer to appoint a New Zealand-based sponsor who assumes legal responsibility for the product. Taevas Global acts as your designated sponsor, ensuring all Medsafe obligations are met from day one. We maintain the regulatory relationship on your behalf so you can focus on commercialisation.
Appointment as your New Zealand regulatory sponsor
Ongoing liaison with Medsafe on your behalf
Management of sponsor obligations under the Medicines Act 1981 and upcoming Therapeutic Products Act
How It Works
From Brief to Board-Ready Intelligence
Our four-stage engagement takes your medical devices company from initial scoping through to a fully established, compliant legal presence in New Zealand.
Step 1 · Day 1-2
Intake and Device Assessment
We begin with a structured intake session to understand your device portfolio, target indications, existing regulatory certifications such as CE marking or TGA registration, and your intended New Zealand launch timeline. This allows us to assess the regulatory classification and identify the most efficient path to market. A tailored engagement plan is produced within 48 hours.
Taevas Approach
Our intake questionnaire covers device classification, intended purpose, existing conformity assessment certificates, supply chain structure, and post-market surveillance capabilities. We cross-reference this information against current Medsafe guidance and the transitional provisions of the forthcoming Therapeutic Products Act to provide an accurate regulatory snapshot from day one.
Market Snapshot
New Zealand Medical Devices Market at a Glance
NZ$0B+
Estimated Market Size
0%
Projected Annual Growth
0+
Active Device Sponsors
0+
WAND-Listed Device Lines
Medsafe Regulatory Transition
New Zealand is transitioning from the Medicines Act 1981 framework to the new Therapeutic Products Act, which will introduce a risk-based classification system more closely aligned with international standards. Medical device manufacturers need to begin preparing for the new regime now to avoid disruption to existing product authorisations. Early engagement with the transitional requirements is a key competitive advantage.
Trans-Tasman Regulatory Alignment
New Zealand and Australia maintain the Trans-Tasman Mutual Recognition Arrangement, which allows products legally sold in one country to generally be sold in the other. For medical devices, this creates a streamlined dual-market entry opportunity when regulatory strategies are coordinated from the outset. Manufacturers with TGA registration often find the New Zealand pathway significantly accelerated.
Public Hospital Procurement Dominance
New Zealand's publicly funded health system, administered through Health New Zealand Te Whatu Ora, accounts for the majority of medical device procurement. Access to this market typically requires PHARMAC assessment for devices funded through the national budget, adding a health technology assessment dimension to the market entry strategy. Understanding procurement cycles and PHARMAC processes is essential for commercial success.
Digital Health and MedTech Innovation
New Zealand has a growing digital health and MedTech innovation ecosystem, supported by government initiatives and a strong university research base. Software as a Medical Device (SaMD) and connected health technologies are attracting increasing regulatory attention from Medsafe as the sector matures. Manufacturers in these categories should expect evolving guidance and benefit from proactive regulatory engagement.
What's Included
Everything in Your Engagement
Every Taevas Global Legal Representation engagement for New Zealand Medical Devices includes these eight core deliverables, providing complete regulatory and commercial coverage from appointment to ongoing compliance.
Sponsor Appointment Agreement
A legally binding agreement formally appointing Taevas Global as your New Zealand regulatory sponsor, executed in compliance with Medsafe requirements and clearly defining responsibilities for both parties.
WAND Notification Package
Complete preparation and submission of your WAND database device notifications, including all required technical documentation, conformity assessment evidence, and device classification justifications.
Regulatory Pathway Report
A detailed written analysis of the current and forthcoming regulatory pathways applicable to your device portfolio in New Zealand, including transitional provisions under the Therapeutic Products Act.
Labelling Compliance Review
A thorough review of your product labelling and Instructions for Use against New Zealand statutory requirements and Medsafe guidance, with a written gap analysis and recommended amendments.
Compliance Calendar
A 12-month forward-looking compliance calendar covering all WAND renewal dates, Medsafe reporting obligations, and key milestones under the incoming Therapeutic Products Act transition.
Post-Market Surveillance Framework
A documented post-market surveillance and adverse event reporting framework aligned with Medsafe requirements and designed to meet the expected standards of the forthcoming Therapeutic Products Act.
Medsafe Correspondence Management
Ongoing management of all official correspondence with Medsafe, including queries, requests for information, and any regulatory actions, with timely escalation and response on your behalf.
Monthly Regulatory Updates
Monthly written briefings covering changes to New Zealand medical device legislation, Medsafe guidance updates, and Therapeutic Products Act implementation progress that may affect your products or compliance posture.
Who This Is For
Built for These Situations
Market Entry
Overseas Manufacturer Entering New Zealand
You are a medical devices manufacturer based outside New Zealand that has identified the market as a commercial opportunity but lacks the in-country legal presence required by Medsafe. You need a qualified sponsor appointed quickly and a clear regulatory roadmap before committing to distribution partnerships. Speed, accuracy, and regulatory credibility are your primary concerns.
Outcome
A fully appointed New Zealand sponsor, completed WAND notifications, and a compliant market entry within six weeks of engagement.
Next Steps
After Legal Representation, Most Clients Move To
FAQ
Common Questions
Get Started
Ready to Map Your New Zealand Opportunity?
Taevas Global provides medical devices manufacturers with the in-country legal representation, regulatory expertise, and commercial network needed to enter and succeed in the New Zealand market. Speak with our team today to begin your compliance journey.
Qualified New Zealand sponsor appointed within two weeks
Full WAND notification management included
Therapeutic Products Act transition readiness built in
Coordinated Trans-Tasman strategy available